Antioxidants and oxidants regulated signal transduction pathways

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 765-770

  Owuor, Edward D ^a   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Apoptosis; Caspases; Gene expression; Mitogen activated protein kinase; Phenolic antioxidants

Indexed keywords

ANTIOXIDANT; CASPASE; COMPLEMENTARY DNA; CYTOCHROME C; HEME OXYGENASE 1; ISOTHIOCYANIC ACID; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZING AGENT; POLYPHENOL DERIVATIVE; TRANSCRIPTION FACTOR; XENOBIOTIC AGENT;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; CHEMOPROPHYLAXIS; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DETOXIFICATION; DIMERIZATION; DISEASE MODEL; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC CODE; GENETIC TRANSFECTION; HOMEOSTASIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; TEA; WILD TYPE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CHEMOPREVENTION; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; NF-E2-RELATED FACTOR 2; OXIDANTS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 0036708902     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01137-1     Document Type: Article

References (66)

1. Gonzalez F.A., Raden D.L., Davis R.J. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266:1991;22159-22163.
2. Alvarez E., Northwood I.C., Gonzalez F.A., Latour D.A., Seth A., Abate C., Curran T., Davis R.J. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266:1991;15277-15285.
3. Marshall C.J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4:1994;82-89.
4. Cobb M.H., Goldsmith E.J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843-14846.
5. Cano E., Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:1995;117-122.
6. Kyriakis J.M., Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays. 18:1996;567-577.
7. Chen Y.R., Wang C.X., Templeton D., Davis R.J., Tan T.H. The role of c-jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C. J. Biol. Chem. 271:1996;31929-31936.
8. Osborn M.T., Chambers T.C. Role of the stress-activated/c-jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J. Biol. Chem. 271:1996;30950-30955.
9. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science. 274:1996;1855-1859.
10. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.
11. Karin M. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. N. Y. Acad. Sci. 851:1998;139-146.
12. Wattenberg L.W. Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole. J. Natl. Cancer Inst. 50:1973;1541-1544.
13. Wattenberg L.W., Coccia J.B., Lam L.K. Inhibitory effects of phenolic compounds on benzo(a)pyrene-induced neoplasia. Cancer Res. 40:1980;2820-2823.
14. King M.M., McCay P.B. Modulation of tumor incidence and possible mechanisms of inhibition of mammary carcinogenesis by dietary antioxidants. Cancer Res. 43:1983;2485-2490.
15. Lam L.K., Fladmoe A.V., Hochalter J.B., Wattenberg L.W. Short time interval effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene. Cancer Res. 40:1980;2824-2828.
16. Sparnins V.L., Chuan J., Wattenberg L.W. Enhancement of glutathione S-transferase activity of the esophagus by phenols, lactones, and benzyl isothiocyanate. Cancer Res. 42:1982;1205-1207.
17. Sparnins V.L., Venegas P.L., Wattenberg L.W. Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. J. Natl. Cancer Inst. 68:1982;493-496.
18. Batzinger R.P., Ou S.Y., Bueding E. Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agents. Cancer Res. 38:1978;4478-4485.
19. Kensler T.W., Egner P.A., Dolan P.M., Groopman J.D., Roebuck B.D. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 47:1987;4271-4277.
20. Yu R., Tan T.H., Kong A.-N.T. Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J. Biol. Chem. 272:1997;28962-28970.
21. DeLong M.J., Prochaska H.J., Talalay P. Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res. 45:1985;546-551.
22. Friling R.S., Bensimon A., Tichauer Y., Daniel V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6258-6262.
23. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:1991;11632-11639.
24. Yu R., Lei W., Mandlekar S., Weber M.J., Der C.J., Wu J., Kong A.-N.T. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274:1999;27545-27552.
25. Yu R., Jiao J.J., Duh J.L., Gudehithlu K., Tan T.H., Kong A.-N.T. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis. 18:1997;451-456.
26. Wasserman W.W., Fahl W.E. Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5361-5366.
27. Li Y., Jaiswal A.K. Regulation of human NAD(P)H: quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J. Biol. Chem. 267:1992;15097-15104.
28. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 265:1990;14648-14653.
29. Prestera T., Holtzclaw W.D., Zhang Y., Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA. 90:1993;2965-2969.
30. Alam J., Stewart D., Touchard C., Boinapally S., Choi A.M., Cook J.L. Nrf2, a cap'n'collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274:1999;26071-26078.
31. Chen C., Yu R., Owuor E.D., Kong A.-N.T. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 23:2000;605-612.
32. Yu R., Chen C., Mo Y.Y., Hebbar V., Owuor E.D., Tan T.H., Kong A.-N.T. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via Nrf2-dependent mechanism. J. Biol. Chem. 275:2000;39907-39913.
33. Yu R., Mandlekar S., Lei W., Fahl W.E., Tan T.H., Kong A.-N.T. p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J. Biol. Chem. 275:2000;2322-2327.
34. Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H: quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14960-14965.
35. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:1997;313-322.
36. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:1999;76-86.
37. Chan K., Kan Y.W. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;12731-12736.
38. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
39. Buttke T.M., Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol. Today. 15:1994;7-10.
40. Slater A., Stefan C., Nobel I., Van Den Dobbelsteen D.J., Orrenius S. Intracellular redox changes during apoptosis. Cell Death Differ. 3:1996;57-62.
41. Briehl M.M., Baker A.F. Modulation of the antioxidant defense as a factor in apoptosis. Cell Death Differ. 3:1996;63-70.
42. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
43. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang C.X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
44. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis[see comments]. Science. 275:1997;1132-1136.
45. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang C.X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
46. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
47. Sen S., M D.I. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett. 307:1992;122-127.
48. Manna S.K., Mukhopadhyay A., Van N.T., Aggarwal B.B. Silymarin suppresses TNF-induced activation of NF-kappa B, c-jun N-terminal kinase, and apoptosis. J. Immunol. 163:1999;6800-6809.
49. Richter M., Ebermann R., Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr. Cancer. 34:1999;88-99.
50. Simizu S., Takada M., Umezawa K., Imoto M. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J. Biol. Chem. 273:1998;26900-26907.
51. Pagliacci M.C., Smacchia M., Migliorati G., Grignani F., Riccardi C., Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer. 30:1994;1675-1682.
52. Lippman S.M., Shin D.M., Lee J.J., Batsakis J.G., Lotan R., Tainsky M.A., Hittelman W.N., Hong W.K. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res. 55:1995;16-19.
53. Samaha H.S., Kelloff G.J., Steele V.E., Rao C.V., Reddy B.S. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3- methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res. 57:1997;1301-1305.
54. Lepley D.M., Pelling J.C. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol. Carcinog. 19:1997;74-82.
55. Reddy B.S., Wang C.X., Samaha H.S., Lubet R., Steele V.E., Kelloff G.J., Rao C.V. Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res. 57:1997;420-425.
56. Huang C., Ma W.Y., Goranson A., Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis. 20:1999;237-242.
57. Yang G.Y., Liao J., Kim K., Yurkow E.J., Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 19:1998;611-616.
58. Yu R., Mandlekar S., Harvey K.J., Ucker D.S., Kong A.-N.T. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res. 58:1998;402-408.
59. Mandlekar S., Kong A.-N.T. Molecular mechanisms of butylated hydroxylanisole-induced toxicity: induction of apoptosis through direct release of cytochrome c. Mol. Pharmacol. 58:2000;431-437.
60. Yu R., Jiao J.J., Duh J.L., Tan T.H., Kong A.-N.T. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-jun N-terminal kinase 1. Cancer Res. 56:1996;2954-2959.
61. Kirlin W.G., Cai J., DeLong M.J., Patten E.J., Jones D.P. Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J. Nutr. 129:1999;1827-1835.
62. Mandlekar S., Yu R., Tan T.H., Kong A.-N.T. Activation of caspase-3 and c-jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis in human breast cancer cells. Cancer Res. 60:2000;5995-6000.
63. Mandlekar S., Hebbar V., Christov K., Kong A.-N.T. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary carcinoma and in human breast cancer cell lines. Cancer Res. 60:2000;6601-6606.
64. Clayson D.B., Iverson F., Nera E.A., Lok E. The significance of induced forestomach tumors. Annu. Rev. Pharmacol. Toxicol. 30:1990;441-463.
65. Mizutani T., Nomura H., Nakanishi K., Fujita S. Hepatotoxicity of butylated hydroxytoluene and its analogs in mice depleted of hepatic glutathione. Toxicol. Appl. Pharmacol. 87:1987;166-176.
66. Yu R., Hebbar V., Kim D., Mandlekar S., Pezzuto J., Kong A.-N.T. Resveratrol inhibits phorbol ester and UV-induced AP-1 activation by interfering with tyrosine kinase and mitogen-activated protein kinase pathways. Mol. Pharm. 60:2000;217-224.